Increased Serum IGFBP-1 and Reduced Insulin Resistance After Roux-En-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes: a 6-Month Follow-Up

Overview

Journal Obes Surg

Date 2018 Apr 26

PMID 29693217

Citations 5

Authors

Zhigao Song

Xiaojian Dai

Hao Yu

Qing Luo

Hongbin Zhang

Liangping Wu

Affiliations

Soon will be listed here.

Abstract

Objective: This study aimed to measure changes of insulin-like growth factor binding protein-1 (IGFBP-1) in patients with type 2 diabetes mellitus (T2D) following gastric bypass surgery.

Methods: A total of 10 patients with T2D underwent laparoscopic Roux-en-Y gastric bypass (RYGB) surgery. Patient height, weight, waist circumference, and hip circumference were measured pre- and post-operatively at 6 months after surgery. Serum samples were collected at 6 months after surgery to determine fasting blood glucose, glycosylated Hb, fasting insulin, C-peptide, and 2-h postprandial blood glucose, insulin, and C-peptide. Serum was collected at 3 days and 6 months after surgery and IGFBP-1 level determined using ELISA. Serum samples were also collected from 30 healthy weight subjects and 27 overweight control subjects.

Results: Body weight, BMI, and waist circumference were significantly improved following RYGB surgery. Blood glucose, fasting blood glucose, 2-h postprandial blood glucose, and HbA1c were also significantly improved. Fasting C-peptide and 2-h postprandial C-peptide were non-significantly reduced. Serum IGFBP-1 significantly increased at 3 days and 6 months after RYGB surgery. Pre-operative serum IGFBP-1 was not significantly different from healthy weight subjects or overweight subjects.

Conclusion: Increased serum level of IGF-binding proteins after RYGB in 6 months is increased post-surgery compared with overweight and healthy weight controls. IGFBP-1 may serve as part of new supplementary criteria for surgical selection and for defining the success of RYGB.

Citing Articles

ASK1-Interacting Protein 1 Acts as a Novel Predictor of Type 2 Diabetes.

Song Z, Chen C, He J, Liu B, Ji W, Wu L Front Endocrinol (Lausanne). 2022; 13:896753.

PMID: 35712257 PMC: 9196954. DOI: 10.3389/fendo.2022.896753.

Profiling of Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Obesity and Their Association With Ox-LDL and Hs-CRP in Adolescents.

Rahman A, Hammad M, Al Khairi I, Cherian P, Al-Sabah R, Al-Mulla F Front Endocrinol (Lausanne). 2021; 12:727004.

PMID: 34394011 PMC: 8355984. DOI: 10.3389/fendo.2021.727004.

Predictors of normalized HbA1c after gastric bypass surgery in subjects with abnormal glucose levels, a 2-year follow-up study.

Ekberg N, Falhammar H, Naslund E, Brismar K Sci Rep. 2020; 10(1):15127.

PMID: 32934313 PMC: 7492212. DOI: 10.1038/s41598-020-72141-0.

Single-Anastomosis Duodenal Jejunal Bypass Improve Glucose Metabolism by Regulating Gut Microbiota and Short-Chain Fatty Acids in Goto-Kakisaki Rats.

Yu X, Wu Z, Song Z, Zhang H, Zhan J, Yu H Front Microbiol. 2020; 11:273.

PMID: 32153548 PMC: 7047167. DOI: 10.3389/fmicb.2020.00273.

The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.

Haywood N, A Slater T, Matthews C, Wheatcroft S Mol Metab. 2018; 19:86-96.

PMID: 30392760 PMC: 6323188. DOI: 10.1016/j.molmet.2018.10.008.

References

Luo J, Murphy L . Differential expression of the insulin-like growth factor binding proteins in spontaneously diabetic rats. J Mol Endocrinol. 1992; 8(2):155-63. DOI: 10.1677/jme.0.0080155. View

Smeu B, Balescu I, Sarbu A, Fica S, Copaescu C . Early Improvement in Glycemic Metabolism after Laparoscopic Sleeve Gastrectomy in Obese Patients - A Prospective Study. Chirurgia (Bucur). 2015; 110(5):430-9. View

Tschop M, Smiley D, Heiman M . Ghrelin induces adiposity in rodents. Nature. 2000; 407(6806):908-13. DOI: 10.1038/35038090. View

Moses A, Young S, Morrow L, OBrien M, Clemmons D . Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 1996; 45(1):91-100. DOI: 10.2337/diab.45.1.91. View

Moreno-Navarrete J, Ortega F, Serino M, Luche E, Waget A, Pardo G . Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond). 2011; 36(11):1442-9. DOI: 10.1038/ijo.2011.256. View

Raverdy V, Baud G, Pigeyre M, Verkindt H, Torres F, Preda C . Incidence and Predictive Factors of Postprandial Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass: A Five year Longitudinal Study. Ann Surg. 2016; 264(5):878-885. DOI: 10.1097/SLA.0000000000001915. View

Urakami T, Kubota S, Nitadori Y, Harada K, Owada M, Kitagawa T . Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. Diabetes Care. 2005; 28(8):1876-81. DOI: 10.2337/diacare.28.8.1876. View

Greenhill C . Liver: Asprosin - new hormone involved in hepatic glucose release. Nat Rev Endocrinol. 2016; 12(6):312. DOI: 10.1038/nrendo.2016.66. View

Matsumoto T, Ishida K, Nakayama N, Kobayashi T, Kamata K . Involvement of NO and MEK/ERK pathway in enhancement of endothelin-1-induced mesenteric artery contraction in later-stage type 2 diabetic Goto-Kakizaki rat. Am J Physiol Heart Circ Physiol. 2009; 296(5):H1388-97. DOI: 10.1152/ajpheart.00043.2009. View

10.

Adams T, Davidson L, Litwin S, Kim J, Kolotkin R, Nanjee M . Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med. 2017; 377(12):1143-1155. PMC: 5737957. DOI: 10.1056/NEJMoa1700459. View

11.

Matsui H, Musicki B, Sopko N, Liu X, Hurley P, Burnett A . Early-stage Type 2 Diabetes Mellitus Impairs Erectile Function and Neurite Outgrowth From the Major Pelvic Ganglion and Downregulates the Gene Expression of Neurotrophic Factors. Urology. 2016; 99:287.e1-287.e7. PMC: 5384100. DOI: 10.1016/j.urology.2016.08.045. View

12.

Brynskov T, Laugesen C, Floyd A, Frystyk J, Sorensen T . The IGF-Axis and Diabetic Retinopathy Before and After Gastric Bypass Surgery. Obes Surg. 2016; 27(2):408-415. DOI: 10.1007/s11695-016-2303-0. View

13.

Gokulakrishnan K, Velmurugan K, Ganesan S, Mohan V . Circulating levels of insulin-like growth factor binding protein-1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118). Metabolism. 2011; 61(1):43-6. DOI: 10.1016/j.metabol.2011.05.014. View

14.

Mohan S, Baylink D . IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol. 2002; 175(1):19-31. DOI: 10.1677/joe.0.1750019. View

15.

Lee P, Lustig R, Lenders C, Baillargeon J, Wilson D . INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 PREDICTS INSULIN SENSITIVITY AND INSULIN AREA-UNDER-THE-CURVE IN OBESE, NONDIABETIC ADOLESCENTS. Endocr Pract. 2015; 22(2):136-42. DOI: 10.4158/EP15885.OR. View

16.

Hjortebjerg R, Laugesen E, Hoyem P, Oxvig C, Stausbol-Gron B, Knudsen S . The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage. Eur J Endocrinol. 2017; 176(5):521-531. DOI: 10.1530/EJE-16-0940. View

17.

Fruhbeck G, Gomez-Ambrosi J . Rationale for the existence of additional adipostatic hormones. FASEB J. 2001; 15(11):1996-2006. DOI: 10.1096/fj.00-0829hyp. View

18.

Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H . Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev. 1999; 15(5):314-22. DOI: 10.1002/(sici)1520-7560(199909/10)15:5<314::aid-dmrr56>3.0.co;2-e. View

19.

Pories W, Swanson M, MacDonald K, Long S, Morris P, Brown B . Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222(3):339-50; discussion 350-2. PMC: 1234815. DOI: 10.1097/00000658-199509000-00011. View

20.

Fruhbeck G . Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015; 11(8):465-77. DOI: 10.1038/nrendo.2015.84. View